Health PEI Formulary Drugs for Oncology
The Health PEI Formulary Drugs for Oncology is a list of oncology medications that are funded by Health PEI through one of two funding channels:
for "health pei pei renal program"
The Health PEI Formulary Drugs for Oncology is a list of oncology medications that are funded by Health PEI through one of two funding channels:
This Annual Report provides an overview of Health PEI's accomplishments, challenges, performance and financial results for 2023-2024.
Investing in infrastructure - More Islanders with chronic kidney disease will benefit from improved kidney care thanks to a new Provincial Renal Clinic. The provincial government – through its capital budget – is investing $2.1 million to construct the new clinic, which will be...
Les reins sont deux organes situés sous les côtes, de part et d’autre de la colonne vertébrale. Chacun a la forme d’un haricot et la taille approximative d’un poing fermé. Les reins servent à éliminer les toxines du sang et à transformer les déchets en urine. Qu’arrive-t-il...
Islanders living with chronic kidney disease will soon benefit from more resources and better access to dialysis treatment and specialists at the renal clinic, says Minister of Health and Wellness Robert Henderson. This week, Health PEI introduced an evening shift that will...
This Annual Report provides an overview of Health PEI's actions and performance results that are linked to the organization’s strategic goals and priorities.
The Health PEI Business Plan 2023-2024 outlines key actions the organization will focus its efforts.
Due to inclement weather and road conditions, the following health services have been impacted: · All public health nursing appointments in Queens County are cancelled · All Provincial Renal Clinic appointments are cancelled · Nurse Practitioner clinic in Morell is cancelled...
This Annual Report provides an overview of Health PEI's accomplishments, challenges, performance and financial results for 2022-2023.
Health PEI’s strategic plan outlines the organization’s direction and guides decision-making and activities over the next three years (2021-2024).